Musculoskeletal Diseases: Degenerative lumbar spine stenosis Musculoskeletal Diseases Degenerative lumbar spine stenosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients 65 and over 2. Unilateral or bilateral neurogenic claudication (NC), ie exercise induced leg pain on walking, relieved in sitting 3. Patient reported limitation of walking tolerance due to symptoms of NC
Exclusion criteria
Exclusion criteria: 1. Cognitive impairment preventing full understanding or participation in the study 2. Evidence of medical conditions such as hip/leg pathology or peripheral vascular disease, which may mimic NC or prevent participation in a shuttle walking test 3. Severe or worsening neurological status 4. Signs/symptoms of cauda equina compression, inflammatory joint disease, signs/symptoms of sinister pathology (unexplained weight loss, unremitting/night-time pain, history of cancer), which may require urgent surgical opinion. This will be determined through subjective and objective examination of patients by the recruiting researcher at the point of screening 5. Exclusion criterion for Home Trial Pilot phase only: previous use of walking aid
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Primary
| Measure | Time frame |
|---|---|
| Shuttle walking crossover test: difference in walking tolerance (measured in metres) between SWT with walking stick and SWT without walking stick. Each shuttle is 10 metres, thus the number of completed shuttles counted by the investigator will be multiplied by 10 to provide an outcome measure in metres. | — |
Countries
United Kingdom